ReviewCurrent cardiology reports2022

Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits.

Meghan E Pauley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.